Esther J. Verschuren

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Sabine Allard, Brenda De Keersmaecker, Anna L. de Goede et al. · Clinical Immunology · 2011 · 119 citations

Life Sciences, Immunology, Infectious Diseases +17

Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes

Carel A. van Baalen, Christophe Guillon, Minus van Baalen et al. · European Journal of Immunology · 2002 · 75 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The loss of immunodominant epitopes affects interferon-γ production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response<i>in vitro</i>

E. G. M. Berkhoff, Martina M. Geelhoed-Mieras, Esther J. Verschuren et al. · Clinical & Experimental Immunology · 2007 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Fluorescent Antigen–Transfected Target Cell Cytotoxic T Lymphocyte Assay for Ex Vivo Detection of Antigen‐Specific Cell‐Mediated Cytotoxicity

Carel A. van Baalen, David Kwa, Esther J. Verschuren et al. · The Journal of Infectious Diseases · 2005 · 28 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Quantitative Analysis of HIV-1 Protease Inhibitors in Cell Lysates Using MALDI-FTICR Mass Spectrometry

Jeroen J. A. van Kampen, Peter C. Burgers, Ronald de Groot et al. · Analytical Chemistry · 2008 · 18 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +15